These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 24521998)
1. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):725-34. PubMed ID: 24521998 [TBL] [Abstract][Full Text] [Related]
2. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Sweeney C; Bernard PS; Factor RE; Kwan ML; Habel LA; Quesenberry CP; Shakespear K; Weltzien EK; Stijleman IJ; Davis CA; Ebbert MT; Castillo A; Kushi LH; Caan BJ Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):714-24. PubMed ID: 24521995 [TBL] [Abstract][Full Text] [Related]
3. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882 [TBL] [Abstract][Full Text] [Related]
4. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients. Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer. Ren X; Song Y; Zhang Y; Wu H; Chen L; Pang J; Zhou L; Shen S; Liang Z BMC Cancer; 2022 May; 22(1):548. PubMed ID: 35568835 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up. Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653 [TBL] [Abstract][Full Text] [Related]
7. Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2. Prat A; Brase JC; Cheng Y; Nuciforo P; Paré L; Pascual T; Martínez D; Galván P; Vidal M; Adamo B; Hortobagyi GN; Baselga J; Ciruelos E Oncologist; 2019 Jul; 24(7):893-900. PubMed ID: 30679318 [TBL] [Abstract][Full Text] [Related]
8. PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study. Wang L; Li Q; Aushev VN; Neugut AI; Santella RM; Teitelbaum S; Chen J Breast Cancer; 2021 Nov; 28(6):1235-1242. PubMed ID: 34003448 [TBL] [Abstract][Full Text] [Related]
9. Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies. Prat A; Chaudhury A; Solovieff N; Paré L; Martinez D; Chic N; Martínez-Sáez O; Brasó-Maristany F; Lteif A; Taran T; Babbar N; Su F J Clin Oncol; 2021 May; 39(13):1458-1467. PubMed ID: 33769862 [TBL] [Abstract][Full Text] [Related]
10. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M; Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648 [TBL] [Abstract][Full Text] [Related]
11. Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes. Kumar N; Zhao D; Bhaumik D; Sethi A; Gann PH BMC Cancer; 2019 Mar; 19(1):215. PubMed ID: 30849944 [TBL] [Abstract][Full Text] [Related]
12. Frequency of breast cancer subtypes among African American women in the AMBER consortium. Allott EH; Geradts J; Cohen SM; Khoury T; Zirpoli GR; Bshara W; Davis W; Omilian A; Nair P; Ondracek RP; Cheng TD; Miller CR; Hwang H; Thorne LB; O'Connor S; Bethea TN; Bell ME; Hu Z; Li Y; Kirk EL; Sun X; Ruiz-Narvaez EA; Perou CM; Palmer JR; Olshan AF; Ambrosone CB; Troester MA Breast Cancer Res; 2018 Feb; 20(1):12. PubMed ID: 29409530 [TBL] [Abstract][Full Text] [Related]
13. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Dawood S; Hu R; Homes MD; Collins LC; Schnitt SJ; Connolly J; Colditz GA; Tamimi RM Breast Cancer Res Treat; 2011 Feb; 126(1):185-92. PubMed ID: 20711652 [TBL] [Abstract][Full Text] [Related]
14. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women. Izadi P; Mehrdad N; Foruzandeh F; Reza NM Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526 [TBL] [Abstract][Full Text] [Related]
15. Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance. Kim HK; Park KH; Kim Y; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Lee JE; Ahn JS; Im YH; Yu JH; Park YH Cancer Res Treat; 2019 Apr; 51(2):737-747. PubMed ID: 30189722 [TBL] [Abstract][Full Text] [Related]
16. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival. Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery. Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768 [TBL] [Abstract][Full Text] [Related]
18. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. Kwan ML; Kroenke CH; Sweeney C; Bernard PS; Weltzien EK; Castillo A; Factor RE; Maxfield KS; Stijleman IJ; Kushi LH; Quesenberry CP; Habel LA; Caan BJ BMC Cancer; 2015 Apr; 15():278. PubMed ID: 25884832 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy. Liu FF; Shi W; Done SJ; Miller N; Pintilie M; Voduc D; Nielsen TO; Nofech-Mozes S; Chang MC; Whelan TJ; Weir LM; Olivotto IA; McCready DR; Fyles AW J Clin Oncol; 2015 Jun; 33(18):2035-40. PubMed ID: 25964246 [TBL] [Abstract][Full Text] [Related]
20. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer. Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]